Elizabeth E. Kim

811 total citations
9 papers, 665 citations indexed

About

Elizabeth E. Kim is a scholar working on Ophthalmology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elizabeth E. Kim has authored 9 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Elizabeth E. Kim's work include Glaucoma and retinal disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Elizabeth E. Kim is often cited by papers focused on Glaucoma and retinal disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Elizabeth E. Kim collaborates with scholars based in United States, Italy and Australia. Elizabeth E. Kim's co-authors include Steven R. Hahn, Thom J. Zimmerman, David S. Friedman, Jason Tan, Harry A. Quigley, Sonali Shah, Jay Margolis, William H. Warren, Hiangkiat Tan and Paul Palmberg and has published in prestigious journals such as Ophthalmology, Investigative Ophthalmology & Visual Science and Journal of Thoracic Oncology.

In The Last Decade

Elizabeth E. Kim

9 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth E. Kim United States 7 508 159 157 57 51 9 665
Susan A. Primo United States 9 446 0.9× 212 1.3× 50 0.3× 12 0.2× 56 1.1× 21 644
Dolly S. Chang United States 18 1.4k 2.7× 1.1k 7.0× 159 1.0× 36 0.6× 31 0.6× 45 1.6k
Rhonda Miller United States 9 512 1.0× 330 2.1× 45 0.3× 17 0.3× 16 0.3× 11 611
Kadircan H. Keskinbora Türkiye 12 110 0.2× 147 0.9× 84 0.5× 14 0.2× 16 0.3× 40 629
Fawzia Djafari Canada 8 247 0.5× 103 0.6× 66 0.4× 17 0.3× 30 0.6× 8 403
Michele C. Lim United States 17 1.1k 2.1× 808 5.1× 225 1.4× 36 0.6× 40 0.8× 36 1.4k
P. Buchholz United States 15 665 1.3× 431 2.7× 289 1.8× 30 0.5× 24 0.5× 39 940
Samuel I. Berchuck United States 17 637 1.3× 577 3.6× 55 0.4× 40 0.7× 19 0.4× 43 841
Joanne Hui Min Quah Singapore 13 117 0.2× 92 0.6× 72 0.5× 4 0.1× 39 0.8× 29 456
Hurshell H. Hunt United States 10 249 0.5× 152 1.0× 72 0.5× 9 0.2× 7 0.1× 20 367

Countries citing papers authored by Elizabeth E. Kim

Since Specialization
Citations

This map shows the geographic impact of Elizabeth E. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. Kim more than expected).

Fields of papers citing papers by Elizabeth E. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth E. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. Kim. The network helps show where Elizabeth E. Kim may publish in the future.

Co-authorship network of co-authors of Elizabeth E. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth E. Kim. A scholar is included among the top collaborators of Elizabeth E. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth E. Kim. Elizabeth E. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Solomon, Benjamin, Elizabeth E. Kim, Yiyun Tang, et al.. (2020). Ophthalmological assessment of crizotinib in advanced non-small-cell lung cancer. Lung Cancer. 145. 167–172. 5 indexed citations
2.
Camidge, D. Ross, et al.. (2019). Renal Effects of Crizotinib in Patients With ALK-Positive Advanced NSCLC. Journal of Thoracic Oncology. 14(6). 1077–1085. 10 indexed citations
3.
Wilner, Keith D., Tiziana Usari, Anna Polli, & Elizabeth E. Kim. (2019). Comparison of Cardiovascular Effects of Crizotinib and Chemotherapy in ALK-Positive Advanced Non-Small-Cell Lung Cancer. Future Oncology. 15(10). 1097–1103. 2 indexed citations
4.
Palmberg, Paul, et al.. (2010). A 12-Week, Randomized, Double-Masked Study of Fixed Combination Latanoprost/Timolol versus Latanoprost or Timolol Monotherapy. European Journal of Ophthalmology. 20(4). 708–718. 19 indexed citations
5.
Zimmerman, Thom J., et al.. (2009). The Impact of Ocular Adverse Effects in Patients Treated With Topical Prostaglandin Analogs: Changes in Prescription Patterns and Patient Persistence. Journal of Ocular Pharmacology and Therapeutics. 25(2). 145–152. 69 indexed citations
6.
Friedman, David S., Steven R. Hahn, Jason Tan, et al.. (2008). Doctor–Patient Communication, Health-Related Beliefs, and Adherence in Glaucoma. Ophthalmology. 115(8). 1320–1327.e3. 245 indexed citations
7.
Friedman, David S., Harry A. Quigley, David Lyon, et al.. (2008). Physician Beliefs and Behaviors Related to Glaucoma Treatment Adherence. Journal of Glaucoma. 17(8). 690–698. 22 indexed citations
8.
Friedman, David S., Harry A. Quigley, Jason Tan, et al.. (2007). Using Pharmacy Claims Data to Study Adherence to Glaucoma Medications: Methodology and Findings of the Glaucoma Adherence and Persistency Study (GAPS). Investigative Ophthalmology & Visual Science. 48(11). 5052–5052. 229 indexed citations
9.
Warren, William H., et al.. (1987). The Way the Ball Bounces: Visual and Auditory Perception of Elasticity and Control of the Bounce Pass. Perception. 16(3). 309–336. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026